News
Dupilumab in combination with other biologic agents is safe and effective for treating various chronic inflammatory conditions.
Dupilumab reduces COPD exacerbations and Type 2 inflammation biomarkers, with strongest benefit in patients with high ...
There are hundreds of conditions that have itch as an underlying symptom, according to Brian S. Kim, MD, MTR, the Sol and Clara Kest professor of dermatology and vice chair of research at Icahn School ...
The number of adults with life-threatening food allergies is on the rise. When researchers at Northwestern University’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results